Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LABRADOR doravirine pharmacokinetics after bariatric surgery in adults with HIV
NL-OMON51582Phase 4Active, not recruiting
- Sponsor
- Ziekenhuisapotheek
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by Ziekenhuisapotheek. Primary endpoint: Effect of bariatric surgery on doravirine pharmacokinetics. Started Aug 2022; status: active, not recruiting.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON51582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51582.